Intratumoral Injection of HSV1716, an Oncolytic Herpes Virus, Is Safe and Shows Evidence of Immune Response and Viral Replication in Young Cancer Patients
瘤内注射溶瘤性疱疹病毒HSV1716是安全的，并且在年轻癌症患者中显示出免疫反应和病毒复制的证据。
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-16-2900
Streby, Keri A; Geller, James I; Currier, Mark A; Warren, Patrick S; Racadio, John M; Towbin, Alexander J; Vaughan, Michele R; Triplet, Melinda; Ott-Napier, Kristy; Dishman, Devon J; Backus, Lori R; Stockman, Beth; Brunner, Marianne; Simpson, Kathleen; Spavin, Robert; Conner, Joe; Cripe, Timothy P
